![Page 1: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/1.jpg)
Outcomes of F and Bevar versus open surgery
Clinical implication of cost efficiency analysis
JP Becquemin on behalf of
Windows investigators Henri Mondor Hospital, University
Paris XII France
![Page 2: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/2.jpg)
![Page 3: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/3.jpg)
Comparison of F- B evar vs open surgery
Financed by the Ministry of Health
Windows Trial
![Page 4: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/4.jpg)
F and Bevar
• High risk patients • Anatomically suitable for f or b evar • Treated in Selected Academic Centers
![Page 5: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/5.jpg)
Open Surgery
• All patients recorded in the mandatory
National the Coding Data Base
![Page 6: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/6.jpg)
![Page 7: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/7.jpg)
![Page 8: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/8.jpg)
End points and Analysis
• 30 D Mortality
• 30 D Severe complications
• 30 D Total Cost
• Three groups according to proximal extent
![Page 9: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/9.jpg)
Group 1
F and Bevar = 184
pts Open Surgery = 1382
pts
![Page 10: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/10.jpg)
Group 2
F and Bevar = 42 pts
Open surgery = 225 pts
![Page 11: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/11.jpg)
Group 3
F and Bevar = 42 pts
Open Surgery = 71 pts
![Page 12: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/12.jpg)
Risk factors
Risk factors F and Bevar
(n=268) Open
(n=1678) p
HTA 81,3% 51,1% <0,0001 Dyslipidemia 63,8% 34,5% <0,0001 Diabete 18,7% 12,5% 0,006 Coronaropathy 43,3% 8,2% <0,0001 Stroke 14,2% 2,1% <0,0001 PAOD 21,3% 14,5% 0,004 Heart failure 13,4% 3,2% <0,0001 Arythmia 19,4% 8,3% <0,0001 Respiratory Insufficiency 34,7% 14,4% <0,0001 Chronic Renal Insuffisiency 32,1% 6,2% <0,0001
![Page 13: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/13.jpg)
0
5
10
15
20
25
Group 1 Group 2 Group 3
F and Bevar Open
4.5% 5 %
Group 1 : Mortality
![Page 14: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/14.jpg)
Group 1 : Complications
Fand B evar (n=184)
Open (n=1382)
p
Amputation 0 (0,0%) 4 (0,3%) 0,46
Myocardial Infarctus 3 (1,6%) 16 (1,2%) 0,58 Stroke 3 (1,6%) 8 (0,6%) 0,11 SCI 2 (1,1%) 6 (0,4%) 0,24
Lung support ≥ 7 D 6 (3,3%) 79 (5,7%) 0,17
Bowel infarct 2 (1,1%) 38 (2,7%) 0,18
Renal Insufficiency 8 (4,3%) 251 (18,2%) <0,0001
Réintervention 22 (11,9%) 124 (9,0%) 0,19
![Page 15: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/15.jpg)
Group 1 Cost calculation
F and Bevar Open surgery
p Mean (±ET) p Mean (±ET) p
Groupe 1 34 425 (±22 021)
<0,0001
14 907 (±12 889)
<0,0001
<0,0001
Groupe 2 37 927 (±11 994) 17 530 (±12 953) <0,0001
Groupe 3 54 710 (±28 919) 45 090 (±45 090) 0,1771
![Page 16: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/16.jpg)
0
5
10
15
20
25
Group 1 Group 2 Group 3
F and Bevar Open
4 %
Group 2 : Mortality
12 %
P = .05
![Page 17: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/17.jpg)
Complications – Group 2
F and B evar (n=42)
Open (n=225)
p
Amputation 1 (2,4%) 0 (0,0%) 0,020
Myocardial Infarctus 1 (2,4%) 2 (0,9%) 0,40
Stroke 1 (2,4%) 2 (0,9%) 0,40
SCI 2 (4,8%) 0 (0,0%) 0,001
Lung supports≥ 7 days 5 (11,9%) 20 (8,9%) 0,54
Bowel ischemia 3 (7,1%) 7 (3,1%) 0,21
Renal insufficiency 4 (9,5%) 68 (30,2%) 0,006
Reintervention 8 (19,0%) 30 (13,3%) 0,33
![Page 18: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/18.jpg)
Group 2: Cost calculation
F and Bevar Open surgery
p Mean (±ET) p Mean (±ET) p
Groupe 1 34 425 (±22 021)
<0,0001
14 907 (±12 889)
<0,0001
<0,0001
Groupe 2 37 927 (±11 994) 17 530 (±12 953) <0,0001
Groupe 3 54 710 (±28 919) 45 090 (±45 090) 0,1771
![Page 19: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/19.jpg)
0
5
10
15
20
25
Group 1 Group 2 Group 3
F and Bevar Open
Group 3 : Mortality
12 %
20 %
![Page 20: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/20.jpg)
Group 3 : Complications
F and bevar (n=42)
Open (n=71)
p
Amputation 0 (0,0%) 0 (0,0%) -
Myocardial infarct 0 (0,0%) 2 (2,8%) 0,27
Stroke 1 (2,4%) 2 (2,8%) 0,89
SCI 7 (16,7%) 10 (14,1%) 0,71
Lung support ≥ 7 days 3 (7,1%) 25 (35,2%) 0,0008
Bowel infarct 1 (2,4%) 6 (8,5%) 0,20
Renal Insufficiency 3 (7,1%) 30 (42,3%) <0,0001
Réintervention 4 (9,5%) 19 (26,8%) 0,028
![Page 21: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/21.jpg)
Group 3 : Cost calculation
F and Bevar Open surgery
p Mean (±ET) p Mean (±ET) p
Groupe 1 34 425 (±22 021)
<0,0001
14 907 (±12 889)
<0,0001
<0,0001
Groupe 2 37 927 (±11 994) 17 530 (±12 953) <0,0001
Groupe 3 54 710 (±28 919) 45 090 (±45 090) 0,1771
![Page 22: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/22.jpg)
Conclusion: F and Bevar
1) In high risk patients with juxtarenal AAA Fbevar is efficient but not cost effective
2) In TAA aneurysms Fbevar is efficient and cost effective
3) In supra renal AAA Fbevar is neither efficient nor cost effective
![Page 23: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/23.jpg)
Windows : Actors • C. Scientifique : JP Becquemin, J Marzelle • CVI : S Haulon, J Marzelle, H Kobeiter • ARCs et TEC : S Idir, N Ady, D Selmane, M Gaba • Analyse Médico Economique URC Eco :
I Durand-Zaleski , MC Clement • DRC APHP: M Quintin, M Dabbech • CODEVEC: A Long, C Mounier-Vellet, C Le Hello, J
Watelet • Imagerie : J Cross, M Majewski • URC St Etienne : S Quenet, B Deygas • Saisie des données Clininfo Lyon: V Pelletier • Centres investigateurs : Lille, Créteil, Lyon, Bordeaux ,
Nantes, Marseille, St Etienne
![Page 24: Outcomes of F and Bevar versus open surgery Clinical ... · PDF fileOutcomes of F and Bevar versus open surgery Clinical implication of cost efficiency analysis JP Becquemin on behalf](https://reader031.vdocument.in/reader031/viewer/2022030412/5a9df8437f8b9ada718be704/html5/thumbnails/24.jpg)
Outcomes of F and Bevar versus open surgery
Clinical implication of cost efficiency analysis
JP Becquemin on behalf of
Windows investigators Henri Mondor Hospital, University
Paris XII France